SCHEMBL217791

SCHEMBL217791

C=COCC1CCC(COC(=O)CCCC(=O)OCC2CCC(COC=C)CC2)CC1

nearest known ligand 0.45

Predicted protein targets (top 8)

geneUniProtsupporting neighboursconfidence
LMNA P02545 2/20 0.45
POLB P06746 1/20 0.42
ALDH1A1 P00352 2/20 0.39
GAA P10253 1/20 0.39
TSHR P16473 1/20 0.34
LPAR1 Q92633 2/20 0.31
LPAR3 Q9UBY5 2/20 0.31
SMYD3 Q9H7B4 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2523203 0.97 LMNA (0.45) LMNAPOLBALDH1A1GAATSHR
SCHEMBL3821626 0.94 LMNA (0.51) LMNAPOLBALDH1A1GAATSHR
SCHEMBL2526794 0.93 LMNA (0.51) LMNAPOLBALDH1A1GAA
SCHEMBL5732993 0.82 LMNA (0.40) LMNAPOLBALDH1A1GAATSHR
SCHEMBL4066822 0.79 JAK2 (0.33) LMNAALDH1A1
SCHEMBL9180809 0.79 LMNA (0.33) LMNA
SCHEMBL278984 0.79 TSHR (0.39) LMNAALDH1A1TSHR
SCHEMBL9180814 0.79 LMNA (0.33) LMNA
SCHEMBL546716 0.78 LMNA (0.44) LMNAPOLBALDH1A1GAATSHR
SCHEMBL27469061 0.77 LMNA (0.67) LMNAPOLBALDH1A1TSHRLPAR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 736 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12098298-B2 Ultra-fast UV-cured material for repairing surface imperfections ILLINOIS TOOL WORKS INC. (US) 2024-09-24 US claimed
EP-2288665-A1 SURFACE-PROMOTED CURE OF ONE-PART CATIONICALLY CURABLE COMPOSITIONS Loctite (R & D) Limited (IE) 2011-03-02 EP claimed
WO-2009141444-A1 SURFACE-PROMOTED CURE OF ONE-PART CATIONICALLY CURABLE COMPOSITIONS LOCTITE (R&D) LIMITED (IE) 2009-11-26 WO claimed
US-20090288769-A1 Surface-Promoted Cure of Cationically Curable Compositions Comprising Vinyl Ethers LOCTITE (R&D)LIMITED (IE) 2009-11-26 US claimed
WO-2008157604-A1 INKJET PRINTING OF MICROLENSES FOR PHOTONIC APPLICATIONS UNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INC. (US) 2008-12-24 WO claimed
US-6916890-B1 Thermally reworkable epoxy resins and compositions based thereon HENKEL CORPORATION (US) 2005-07-12 US claimed
US-6706779-B2 Radiation curable compositions containing alkenyl ether functional polyisobutylenes DOW CORNING CORPORATION 2004-03-16 US claimed
US-6703433-B1 LOW CURE ENERGY, VAPOR BARRIERS, DAMPING, HIGH REFRACTIVE INDEX; CORROSION RESISTANCE, TOUGHNESS, TENSILE STRENGTH DOW CORNING CORPORATION 2004-03-09 US claimed
WO-2003031492-A1 THERMALLY REWORKABLE EPOXY RESINS AND COMPOSITIONS BASED THEREO N HENKEL CORPORATION (US) 2003-04-17 WO claimed
EP-1297040-A1 RADIATION CURABLE COMPOSITIONS CONTAINING ALKENYL ETHER FUNCTIONAL POLYISOBUTYLENES Dow Corning Corporation (US) 2003-04-02 EP claimed
US-20020028303-A1 Radiation curable compositions containing alkenyl ether functional polyisobutylenes DOW CORNING CORPORATION CO1232 2002-03-07 US claimed
WO-2001088003-A1 RADIATION CURABLE COMPOSITIONS CONTAINING ALKENYL ETHER FUNCTIONAL POLYISOBUTYLENES DOW CORNING CORPORATION (US) 2001-11-22 WO claimed
US-12638772-B2 Resist underlayer film-forming composition NISSAN CHEMICAL CORPORATION (JP) 2026-05-26 US disclosed
US-12631964-B2 Resist underlayer film-forming composition NISSAN CHEMICAL CORPORATION (JP) 2026-05-19 US disclosed
EP-4565378-B1 METHODS FOR PRODUCING OPTICAL EFFECT LAYERS COMPRISING MAGNETIC OR MAGNETIZABLE PIGMENT PARTICLES AND EXHIBITING ONE OR MORE INDICIA SICPA HOLDING SA (CH) 2026-05-06 EP disclosed
EP-4499761-B1 PRINTING INK FUJIFILM SPECIALITY INK SYSTEMS LTD (GB) 2026-05-06 EP disclosed
US-5516455-A Polymer dispersed liquid crystals in radiation curable electron-rich alkene-thiol polymer mixtures LOCTITE CORPORATION (US) 1996-05-14 US disclosed
EP-0649444-A4 POLYMER DISPERSED LIQUID CRYSTALS IN ELECTRON-RICH ALKENE-THIOL POLYMERS. LOCTITE CORP (US) 1995-07-26 EP disclosed
EP-0649444-A1 POLYMER DISPERSED LIQUID CRYSTALS IN ELECTRON-RICH ALKENE-THIOL POLYMERS LOCTITE CORPORATION (US) 1995-04-26 EP disclosed
WO-1994025508-A1 POLYMER DISPERSED LIQUID CRYSTALS IN ELECTRON-RICH ALKENE-THIOL POLYMERS LOCTITE CORPORATION (US) 1994-11-10 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12638772-B2 Resist underlayer film-forming composition RFC2, RFC1, RFC4 LMNA 48/4885POLB 1760/4885ALDH1A1 2183/4885
US-12631964-B2 Resist underlayer film-forming composition TET1, OGG1, TET3 LMNA 361/4885POLB 1648/4885ALDH1A1 2237/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.